Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
İbrahim Tekedereli(Inonu University), Bülent Özpolat(The University of Texas MD Anderson Cancer Center)
Cited by 118
Related Papers
Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer
|Cell Death and Disease|2014|257
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells
|International Journal of Oncology|2015|114
FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
|Oncotarget|2016|114